These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15887723)

  • 61. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reconstruction of corneal epithelium with cryopreserved corneal limbal stem cells in a rabbit model.
    Qu L; Yang X; Wang X; Zhao M; Mi S; Dou Z; Wang H
    Vet J; 2009 Mar; 179(3):392-400. PubMed ID: 18023216
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ocular surface reconstruction in graft-versus-host disease with HLA-identical living-related allogeneic cultivated limbal epithelium after hematopoietic stem cell transplantation from the same donor.
    Meller D; Fuchsluger T; Pauklin M; Steuhl KP
    Cornea; 2009 Feb; 28(2):233-6. PubMed ID: 19158575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preoperative evaluation of cultured human corneal limbal epithelium on amniotic membrane by confocal microscopy.
    Mimura T; Yamagami S; Usui T; Yokoo S; Ono K; Honda N; Kaneda A; Sugisaki K; Sayegh RR; Amano S
    Curr Eye Res; 2007 May; 32(5):407-11. PubMed ID: 17514525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quality of life after limbal transplants.
    Miri A; Mathew M; Dua HS
    Ophthalmology; 2010 Mar; 117(3):638, 638.e1-3. PubMed ID: 20189034
    [No Abstract]   [Full Text] [Related]  

  • 66. The application of human amniotic membrane in the surgical management of limbal stem cell deficiency.
    Le Q; Deng SX
    Ocul Surf; 2019 Apr; 17(2):221-229. PubMed ID: 30633967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison between cultivated and conventional limbal stem cell transplantation for Stevens-Johnson syndrome.
    Ang LP; Sotozono C; Koizumi N; Suzuki T; Inatomi T; Kinoshita S
    Am J Ophthalmol; 2007 Jan; 143(1):178-80. PubMed ID: 17188066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Vera LS; Gueudry J; Delcampe A; Roujeau JC; Brasseur G; Muraine M
    Cornea; 2009 May; 28(4):401-7. PubMed ID: 19411958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autologous transplantation of rabbit limbal epithelia cultured on fibrin gels for ocular surface reconstruction.
    Talbot M; Carrier P; Giasson CJ; Deschambeault A; Guérin SL; Auger FA; Bazin R; Germain L
    Mol Vis; 2006 Feb; 12():65-75. PubMed ID: 16479251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of amniotic membrane transplantation in cases of symblepharon.
    Patel AP; Satani DR; Singh S; Desai S
    J Indian Med Assoc; 2012 Jun; 110(6):388-9. PubMed ID: 23360041
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation, indications and results of human amniotic membrane transplantation for ocular surface disorders.
    Alió JL; Abad M; Scorsetti DH
    Expert Rev Med Devices; 2005 Mar; 2(2):153-60. PubMed ID: 16293052
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sight and comfort: complex procedures in end-stage Stevens-Johnson syndrome.
    Geerling G; Liu CS; Dart JK; Sieg P; Herold J; Collin JR
    Eye (Lond); 2003 Jan; 17(1):89-91. PubMed ID: 12579177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ocular surface reconstruction: recent advances and future outlook.
    Yiu SC; Thomas PB; Nguyen P
    Curr Opin Ophthalmol; 2007 Nov; 18(6):509-14. PubMed ID: 18163004
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ocular surface reconstruction update.
    Shimmura S; Tsubota K
    Curr Opin Ophthalmol; 2002 Aug; 13(4):213-9. PubMed ID: 12165702
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Current status and recommendation of ocular surface disease in China].
    Xie LX
    Zhonghua Yan Ke Za Zhi; 2007 Jan; 43(1):4-6. PubMed ID: 17442153
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Amniotic membrane transplantation for ocular surface reconstruction: indications and outcomes.
    Maharajan VS; Shanmuganathan V; Currie A; Hopkinson A; Powell-Richards A; Dua HS
    Clin Exp Ophthalmol; 2007 Mar; 35(2):140-7. PubMed ID: 17362455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Amniotic membrane transplantation for reconstruction of the ocular surface].
    Kruse FE; Meller D
    Ophthalmologe; 2001 Sep; 98(9):801-10. PubMed ID: 11594219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changing concepts in the management of severe ocular surface disease over twenty-five years.
    Holland EJ; Schwartz GS
    Cornea; 2000 Sep; 19(5):688-98. PubMed ID: 11009321
    [No Abstract]   [Full Text] [Related]  

  • 79. [Transplantation of amniotic membrane for reconstruction of the eye surface].
    Kruse FE; Rohrschneider K; Völcker HE
    Ophthalmologe; 1998 Feb; 95(2):114-9. PubMed ID: 9545790
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Ex-vivo expansion of cornea stem cells. Experimental principles and initial clinical results].
    Meller D; Kruse F
    Ophthalmologe; 2001 Sep; 98(9):811-7. PubMed ID: 11594220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.